SARS-CoV-2 uses major endothelial integrin αvβ3 to cause vascular dysregulation in-vitro during COVID-19

Authors:

Nader Danielle, Deli Mária A., Fletcher Nicola, Curley Gerard F., Kerrigan Steven W.

Journal:

Date of publication:

Wednesday, 23 June, 2021

Volume:

Issue:

Pages:

e0253347

EVAg connections:

Research funded by EVAg

Published by EVAg end-user

EVAg